223 related articles for article (PubMed ID: 37336884)
1. Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling.
Roy MJ; Surudoi MG; Kropp A; Hou J; Dai W; Hardy JM; Liang LY; Cotton TR; Lechtenberg BC; Dite TA; Ma X; Daly RJ; Patel O; Lucet IS
Nat Commun; 2023 Jun; 14(1):3542. PubMed ID: 37336884
[TBL] [Abstract][Full Text] [Related]
2. PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization.
Lopez ML; Lo M; Kung JE; Dudkiewicz M; Jang GM; Von Dollen J; Johnson JR; Krogan NJ; Pawłowski K; Jura N
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15495-15504. PubMed ID: 31311869
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3.
Torosyan H; Paul MD; Forget A; Lo M; Diwanji D; Pawłowski K; Krogan NJ; Jura N; Verba KA
Nat Commun; 2023 Jun; 14(1):3543. PubMed ID: 37336883
[TBL] [Abstract][Full Text] [Related]
4. Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family.
Hou J; Nguyen EV; Surudoi M; Roy MJ; Patel O; Lucet IS; Ma X; Daly RJ
Sci Signal; 2022 Feb; 15(722):eabj3554. PubMed ID: 35192416
[TBL] [Abstract][Full Text] [Related]
5. The PEAK family of pseudokinases, their role in cell signalling and cancer.
Patel O; Roy MJ; Murphy JM; Lucet IS
FEBS J; 2020 Oct; 287(19):4183-4197. PubMed ID: 31599110
[TBL] [Abstract][Full Text] [Related]
6. Production and purification of the PEAK pseudokinases for structural and functional studies.
Patel O; Surudoi M; Dai W; Hardy JM; Roy MJ; Lucet IS
Methods Enzymol; 2022; 667():1-35. PubMed ID: 35525538
[TBL] [Abstract][Full Text] [Related]
7. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases.
Liu L; Phua YW; Lee RS; Ma X; Jenkins Y; Novy K; Humphrey ES; Chan H; Shearer R; Ong PC; Dai W; Saunders DN; Lucet IS; Daly RJ
J Biol Chem; 2016 Oct; 291(41):21571-21583. PubMed ID: 27531744
[TBL] [Abstract][Full Text] [Related]
8. SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase.
Ounoughene Y; Fourgous E; Boublik Y; Saland E; Guiraud N; Recher C; Urbach S; Fort P; Sarry JE; Fesquet D; Roche S
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944965
[TBL] [Abstract][Full Text] [Related]
9. Piquing our interest: Insights into the role of PEAK3 in signaling and disease.
Paul MD; Torosyan H; Jura N
Sci Signal; 2022 Feb; 15(722):eabm9396. PubMed ID: 35192418
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine 221 in Crk regulates adhesion-dependent membrane localization of Crk and Rac and activation of Rac signaling.
Abassi YA; Vuori K
EMBO J; 2002 Sep; 21(17):4571-82. PubMed ID: 12198159
[TBL] [Abstract][Full Text] [Related]
11. Interactions between Src homology (SH) 2/SH3 adapter proteins and the guanylnucleotide exchange factor SOS are differentially regulated by insulin and epidermal growth factor.
Okada S; Pessin JE
J Biol Chem; 1996 Oct; 271(41):25533-8. PubMed ID: 8810325
[TBL] [Abstract][Full Text] [Related]
12. Paxillin interactions.
Turner CE
J Cell Sci; 2000 Dec; 113 Pt 23():4139-40. PubMed ID: 11069756
[TBL] [Abstract][Full Text] [Related]
13. 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression.
Freeman AK; Morrison DK
Semin Cell Dev Biol; 2011 Sep; 22(7):681-7. PubMed ID: 21884813
[TBL] [Abstract][Full Text] [Related]
14. Interaction between Dab1 and CrkII is promoted by Reelin signaling.
Chen K; Ochalski PG; Tran TS; Sahir N; Schubert M; Pramatarova A; Howell BW
J Cell Sci; 2004 Sep; 117(Pt 19):4527-36. PubMed ID: 15316068
[TBL] [Abstract][Full Text] [Related]
15. Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway.
Saleh T; Jankowski W; Sriram G; Rossi P; Shah S; Lee KB; Cruz LA; Rodriguez AJ; Birge RB; Kalodimos CG
Nat Chem Biol; 2016 Feb; 12(2):117-23. PubMed ID: 26656091
[TBL] [Abstract][Full Text] [Related]
16. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
[TBL] [Abstract][Full Text] [Related]
17. Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms.
Katso RM; Pardo OE; Palamidessi A; Franz CM; Marinov M; De Laurentiis A; Downward J; Scita G; Ridley AJ; Waterfield MD; Arcaro A
Mol Biol Cell; 2006 Sep; 17(9):3729-44. PubMed ID: 16775008
[TBL] [Abstract][Full Text] [Related]
18. Looking lively: emerging principles of pseudokinase signaling.
Sheetz JB; Lemmon MA
Trends Biochem Sci; 2022 Oct; 47(10):875-891. PubMed ID: 35585008
[TBL] [Abstract][Full Text] [Related]
19. Identification of two signaling submodules within the CrkII/ELMO/Dock180 pathway regulating engulfment of apoptotic cells.
Tosello-Trampont AC; Kinchen JM; Brugnera E; Haney LB; Hengartner MO; Ravichandran KS
Cell Death Differ; 2007 May; 14(5):963-72. PubMed ID: 17304244
[TBL] [Abstract][Full Text] [Related]
20. Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells.
Vallés AM; Beuvin M; Boyer B
J Biol Chem; 2004 Oct; 279(43):44490-6. PubMed ID: 15308668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
